Elimination af hepatitis C-virus i Danmark

Anna Døssing, Birgitte Thorup Røge, Lone Galmstrup Madsen, Alex Lund Laursen, Jesper Bach Hansen, Jens Bukh, Nina Weis

Publikation: Bidrag til tidsskriftArtikelForskningpeer review

Abstrakt

In Denmark, about 50% of patients with chronic hepatitis C virus (HCV) infection are undiagnosed. Since 2014, therapy containing direct-acting antivirals (DAA) has proven efficient and is available to all patients, who have a chronic HCV infection and a Danish personal identification number. The World Health Organization has a goal of elimination of viral hepatitis in 2030. Elimination of HCV in Denmark should focus on reducing HCV transmission, incidence and prevalence, combined with treatment with DAA of all infected patients. Micro-elimination strategies may play a major role, but a national strategy is lacking.

Bidragets oversatte titelElimination of hepatitis C virus in Denmark
OriginalsprogDansk
ArtikelnummerV08190481
Sider (fra-til)1762-1765
Antal sider4
TidsskriftUgeskrift for laeger
Vol/bind182
Udgave nummer19
StatusUdgivet - 24 feb. 2020

Fingeraftryk Udforsk hvilke forskningsemner 'Elimination af hepatitis C-virus i Danmark' indeholder.

Citationsformater